Annotations: 6TUB

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B, C, D, E A, B, C, D, E, F	PF08035	Opioids neuropeptide (Op_neuropeptide)	Opioids neuropeptide	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D, E A, B, C, D, E, F	Beta-endorphin	protein binding binding signaling receptor binding melanocortin receptor binding G protein-coupled receptor binding neuropeptide receptor binding type 1 melanocortin receptor binding type 3 melanocortin receptor binding type 4 melanocortin receptor binding hormone activity molecular function activator activity molecular function regulator activity signaling receptor regulator activity receptor ligand activity protein binding binding signaling receptor binding melanocortin receptor binding G protein-coupled receptor binding neuropeptide receptor binding type 1 melanocortin receptor binding type 3 melanocortin receptor binding type 4 melanocortin receptor binding hormone activity molecular function activator activity molecular function regulator activity signaling receptor regulator activity receptor ligand activity signaling receptor activator activity	cellular response to stimulus regulation of biological process regulation of cellular process response to stimulus signaling biological regulation cell communication G protein-coupled receptor signaling pathway cellular process signal transduction neuropeptide signaling pathway multicellular organismal process system process circulatory system process cellular response to stimulus regulation of biological process regulation of cellular process response to stimulus signaling biological regulation cell communication G protein-coupled receptor signaling pathway cellular process signal transduction neuropeptide signaling pathway multicellular organismal process system process circulatory system process regulation of blood pressure regulation of biological quality blood circulation regulation of tumor necrosis factor production negative regulation of biological process negative regulation of tumor necrosis factor production cytokine production regulation of cytokine production negative regulation of cellular process regulation of multicellular organismal process negative regulation of macromolecule metabolic process regulation of biosynthetic process negative regulation of metabolic process tumor necrosis factor superfamily cytokine production negative regulation of cytokine production regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process tumor necrosis factor production regulation of gene expression negative regulation of gene expression regulation of tumor necrosis factor superfamily cytokine production biosynthetic process negative regulation of biosynthetic process negative regulation of macromolecule biosynthetic process negative regulation of tumor necrosis factor superfamily cytokine production metabolic process regulation of macromolecule biosynthetic process macromolecule metabolic process negative regulation of multicellular organismal process regulation of metabolic process regulation of localization corticosterone secretion regulation of system process regulation of glucocorticoid secretion localization regulation of steroid hormone secretion regulation of hormone levels lipid transport regulation of corticosteroid hormone secretion establishment of localization regulation of secretion endocrine hormone secretion lipid export from cell glucocorticoid secretion regulation of endocrine process corticosteroid hormone secretion regulation of corticosterone secretion regulation of hormone secretion transport steroid hormone secretion regulation of lipid transport organic hydroxy compound transport hormone secretion secretion by cell regulation of secretion by cell signal release regulation of signaling secretion regulation of transport lipid localization export from cell cell-cell signaling endocrine process regulation of lipid localization macromolecule localization hormone transport regulation of cell communication carbohydrate metabolic process energy derivation by oxidation of organic compounds glycogen metabolic process primary metabolic process regulation of generation of precursor metabolites and energy generation of precursor metabolites and energy regulation of polysaccharide metabolic process regulation of primary metabolic process glucan metabolic process polysaccharide metabolic process energy reserve metabolic process regulation of glycogen metabolic process regulation of carbohydrate metabolic process intracellular signal transduction calcium-mediated signaling intracellular signaling cassette positive regulation of cell communication positive regulation of signal transduction positive regulation of biological process regulation of signal transduction positive regulation of response to stimulus positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway regulation of G protein-coupled receptor signaling pathway positive regulation of cellular process adenylate cyclase-activating G protein-coupled receptor signaling pathway positive regulation of G protein-coupled receptor signaling pathway regulation of response to stimulus adenylate cyclase-modulating G protein-coupled receptor signaling pathway regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway positive regulation of signaling pigmentation cellular pigmentation response to nutrient levels regulation of appetite response to hormone response to chemical response to endogenous stimulus response to peptide hormone response to oxygen-containing compound response to nitrogen compound response to melanocyte-stimulating hormone oxytocin production positive regulation of macromolecule biosynthetic process positive regulation of metabolic process positive regulation of biosynthetic process positive regulation of macromolecule metabolic process regulation of oxytocin production positive regulation of gene expression positive regulation of oxytocin production positive regulation of DNA-templated transcription RNA metabolic process nucleobase-containing compound metabolic process RNA biosynthetic process nucleic acid biosynthetic process DNA-templated transcription regulation of RNA metabolic process transcription by RNA polymerase II regulation of nucleobase-containing compound metabolic process regulation of RNA biosynthetic process regulation of transcription by RNA polymerase II positive regulation of transcription by RNA polymerase II nucleobase-containing compound biosynthetic process nucleic acid metabolic process positive regulation of RNA metabolic process positive regulation of RNA biosynthetic process regulation of DNA-templated transcription chemical homeostasis homeostatic process glucose homeostasis carbohydrate homeostasis	membrane-bounded organelle intracellular anatomical structure intracellular vesicle intracellular membrane-bounded organelle endomembrane system intracellular organelle cellular anatomical structure cytoplasmic vesicle organelle secretory granule secretory vesicle cytoplasm vesicle extracellular region membrane-bounded organelle intracellular anatomical structure intracellular vesicle intracellular membrane-bounded organelle endomembrane system intracellular organelle cellular anatomical structure cytoplasmic vesicle organelle secretory granule secretory vesicle cytoplasm vesicle extracellular region vesicle lumen membrane-enclosed lumen cytoplasmic vesicle lumen secretory granule lumen intracellular organelle lumen organelle lumen extracellular space

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D, E A, B, C, D, E, F	IPR013531	Pro-opiomelanocortin/corticotropin, ACTH, central region	Domain
A, B, C, D, E A, B, C, D, E, F	IPR050878	Pro-opiomelanocortin-derived peptides	Family
A, B, C, D, E A, B, C, D, E, F	IPR013532	Opiodes neuropeptide	Domain
A, B, C, D, E A, B, C, D, E, F	IPR013593	Pro-opiomelanocortin N-terminal	Domain
A, B, C, D, E A, B, C, D, E, F	IPR001941	Pro-opiomelanocortin	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D, E A, B, C, D, E, F	Pharos: P01189	obesity disorder obesity due to pro-opiomelanocortin deficiency ACTH-dependent Cushing syndrome sick sinus syndrome nephrocalcinosis hypertensive disorder renal cell carcinoma synovitis early myoclonic encephalopathy hypertrophic cardiomyopathy diabetes insipidus myasthenia gravis glomerulonephritis potassium deficiency disease long QT syndrome obesity disorder obesity due to pro-opiomelanocortin deficiency ACTH-dependent Cushing syndrome sick sinus syndrome nephrocalcinosis hypertensive disorder renal cell carcinoma synovitis early myoclonic encephalopathy hypertrophic cardiomyopathy diabetes insipidus myasthenia gravis glomerulonephritis potassium deficiency disease long QT syndrome cardiomyopathy melanoma diabetes mellitus sarcomatoid renal cell carcinoma fatty liver disease osteoporosis Hypoxia monogenic obesity chondrocalcinosis multiple sclerosis cocaine abuse gout visual epilepsy collecting duct carcinoma ectopic ACTH secretion syndrome bipolar disorder epilepsy proteinuria spastic quadriplegia subvalvular aortic stenosis facial paralysis dissociative amnesia chromophobe renal cell carcinoma cocaine dependence penile disease congestive heart failure pneumonia epilepsy with generalized tonic-clonic seizures acute kidney tubular necrosis calcinosis cystitis restless legs syndrome melancholia opsoclonus-myoclonus syndrome cholestasis papillary renal cell carcinoma endogenous depression West syndrome kidney disease heroin dependence acute liver failure spastic monoplegia hyperaldosteronism Cushing syndrome adrenal cortex disease eye disease substance withdrawal syndrome rhabdomyoma cerebral palsy hypotensive disorder athetoid cerebral palsy Dravet syndrome autism urinary tract infection pancreas disease inherited lipid metabolism disorder heart failure constipation disorder pituitary cancer acquired metabolic disease sleep-wake disorder breast carcinoma acute kidney failure spastic cerebral palsy Addison disease cutaneous melanoma alcohol abuse hypoglycemia hypopituitarism developmental and epileptic encephalopathy familial infantile myoclonic epilepsy hypothyroidism anxiety disorder type 2 diabetes mellitus pain agnosia immune system disease inborn carbohydrate metabolic disorder intracerebral hemorrhage myocardial ischemia acromegaly X-linked adrenal hypoplasia congenita coronary artery disease spastic diplegia Cushing disease due to pituitary adenoma psychiatric disorder adenoma cancer hyperglycemia malignant glioma hypogonadism depressive disorder amnestic disorder digestive system disease mixed cerebral palsy mood disorder clear cell renal carcinoma eating disorder pituitary apoplexy acquired hyperprolactinemia pneumonitis Spasmus nutans burn Nelson syndrome neurotic disorder renal carcinoma amenorrhea familial avascular necrosis of femoral head

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.